Details
Product Name in the RMS: Amoxicillin/Clavulanic acid Actavis 875/125 mg film-coated tablets
MR Number: AT/H/0948/002
Date of outcome: 03.09.2013
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Initial Application Generic Chemical Substance Prescription Only |
Active Substances |
amoxicillin 875 mg clavulanic acid 125 mg |
Form | Film coated tablet |
MA Holder in the RMS |
Actavis Group PTC ehf. Reykjavikurvegur 76-78 IS-220 Hafnarfjordur Iceland |
RMS | Austria |
Date of last change | 15.12.2020 |
ATC-Code |
J01CR02 Amoxicillin and enzyme inhibitor |
CMS Country | Domestic Product Name |
---|---|
Estonia | |
Hungary | |
Iceland | Amoxicillin/Clavulanic acid Actavis 875 mg/125 mg Filmuhúðuð tafla |
Latvia | Amoxicillin/Clavulanic acid Actavis 875 mg/125 mg apvalkotās tabletes |
Lithuania | Amoxicillin/Clavulanic acid Actavis 875 mg/125 mg plėvele dengtos tabletės |
Documents | |
---|---|
PAR: | AT_H_0948_002_PAR.pdf (04.12.2018) |
PARSummary: | AT_H_0948_002_PARSummary.pdf (04.12.2018) |
FinalSPC: | AT_H_0948_002_FinalSPC_1of2.pdf (15.12.2020) |
FinalSPC: | AT_H_0948_002_FinalSPC_2of2.pdf (15.12.2020) |
FinalPL: | AT_H_0948_002_FinalPL.pdf (04.12.2018) |
FinalLabelling: | AT_H_0948_002_FinalLabelling_1of2.pdf (15.12.2020) |
FinalLabelling: | AT_H_0948_002_FinalLabelling_2of2.pdf (15.12.2020) |
Finalised Product Information: | AT_H_0948_002_FinalPI_1of2.pdf (15.12.2020) |
Finalised Product Information: | AT_H_0948_002_FinalPI_2of2.pdf (15.12.2020) |